StockData
EDAP TMS SA logo

EDAP TMS SA (FOCL) company profile

FOCLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 5, 2026Score 0/30
$2.84−0.33 (-10.41%)

Close on Nov 17, 2026Market cap $106.58MP/E –Yield –

About Edap Tms

Electromedical & Electrotherapeutic Apparatus, SIC 3845

EDAP TMS S.A. develops, manufactures, and markets non-invasive therapeutic ultrasound and energy-based medical devices. Its core operations center on High Intensity Focused Ultrasound (HIFU) technology, featuring the Focal One robotic system for the ablation of prostate tissue. The company also offers legacy urology products, such as extracorporeal shock wave lithotripsy systems, related consumables, maintenance services, and distributed third-party medical equipment. Its primary customers are urologists and gynecologists operating within public, private, and academic hospitals as well as clinics.

The company is headquartered in Vaulx-en-Velin, France, and operates globally across the United States, Europe, Asia, and other international territories. It maintains a direct sales force in the United States, France, Germany, the United Kingdom, Switzerland, Scandinavia, Malaysia, and South Korea. In addition, it distributes legacy products directly in Japan, South Korea, and Malaysia, while serving healthcare providers across Latin America, the Middle East, and wider Asia through independent distribution partners.

Summary of the business section of Edap Tms's latest annual report, written by StockData.

Company profile

Company

Legal name
EDAP TMS SA
Founded
1979
Headquarters
69120 Vaulx En Velin, I0
Address
Parc D'Activites La Poudrette Lamartine, 4 Rue Du Dauphine 69120
Phone
33672643508
Employees
289, Dec 31, 2025
Industry
Electromedical & Electrotherapeutic Apparatus
Fiscal year ends
December 31
Auditor
KPMG S.A., Lyon, France

Stock & identifiers

Ticker
FOCL
Former tickers
EDAP until Jun 1, 2026
Exchange
Nasdaq
IPO date
Aug 1, 1997
Shares outstanding
38M, Aug 14, 2026
Public float
$61.85M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
SEC CIK
1041934
CUSIP
268311107
ISIN
US2683111072
FIGI
BBG000C2CL29
Share class FIGI
BBG001SB3ML7
LEI
9695007G9BC43P81WC36
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Ryan RhodesChief Executive Officer, Director626,649
Steven AnnenSVP, Marketing & Product Mgmt.136,490
Sanket ShahGeneral Counsel & Corp Sec72,500
Kenneth S. MobeckChief Financial Officer181,610
Francois Mattieu DietschChief Accounting Officer12,000
David R. HornDirector10,000
Fran SchulzDirector15,100
Joshua LevineDirector45,000
Lance WillseyDirector1,291,780
Glendon E. French IIIDirector–

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$1.74M$2.66M$860.48K$62–
FY2024$1.28M$768.59K$738.07K$42–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsOption awardsIncentive payOtherTotalvs. prior year
Ryan Rhodes
Chief Executive Officer
$673.10K$283.90K$390.00K$379.66K$14.00K$1.74M+36%
Kenneth S. Mobeck
Chief Financial Officer
$460.00K$93.69K$280.50K$158.56K$14.00K$1.01M-4%
Steven Annen
Executive Vice President, Marketing and Product Management
$336.18K$70.36K$210.38K$70.06K$11.74K$713.38K+69%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we employed 289 employees worldwide, with approximately 24% based in the United States and the remainder located internationally.”

See a number that looks wrong?